These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 484634)

  • 1. Pharmacokinetics of norethindrone acetate in women.
    Singh H; Uniyal JP; Jha P; Murugesan K; Takkar D; Hingorani V; Laumas KR
    Am J Obstet Gynecol; 1979 Oct; 135(3):409-14. PubMed ID: 484634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate.
    Singh H; Uniyal JP; Jha P; Takker D; Murguesan K; Hingorani V; Laumas KR
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):302-8. PubMed ID: 7058686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration.
    Mills TM; Lin TJ; Braselton WE; Ellegood JO; Mahesh VB
    Am J Obstet Gynecol; 1976 Dec; 126(8):987-92. PubMed ID: 998688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of norethindrone in Indian Women.
    Prasad KV; Rao BS; Sivakumar B; Prema K
    Contraception; 1979 Jul; 20(1):77-90. PubMed ID: 477319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic clearance rate and urinary excretion of oral contraceptive drugs. I. Norethindrone.
    Mills TM; Lin TJ; Hernandez-Ayup S; Greenblatt RB; Ellegood JO; Mahesh VB
    Am J Obstet Gynecol; 1974 Nov; 120(6):764-72. PubMed ID: 4429084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of norethindrone and lynestrenol studied by HPLC (author's transl)].
    Yasuda J; Fujii M; Tsukamoto K; Yamamoto T; Honjo H; Okada H
    Nihon Naibunpi Gakkai Zasshi; 1981 Aug; 57(8):1159-66. PubMed ID: 7319102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quingestanol acetate metabolism in women.
    Di Carlo FJ; Loo JC; Aceto T; Zuleski FR; Barr WH
    Pharmacology; 1974; 11(5):287-303. PubMed ID: 4853997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissappearance of 1 alpha-3H-chlormadinone acetate from the plasma of women.
    Dugwekar YG; Narula RK; Laumas KR
    Contraception; 1973 Jan; 7(1):27-45. PubMed ID: 4134033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disappearance of (14,15-3H)d,1-norgestrel from plasma and its distribution in the reproductive tract of women.
    Uniyal JP; Buckshee K; Sharma U; Laumas KR
    Acta Endocrinol (Copenh); 1976 Aug; 82(4):851-64. PubMed ID: 947291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance of [1alpha-3H]-chlormadinone acetate in the plasma and red cells of rhesus monkey.
    Laumas V; Farooq A; Laumas KR
    J Steroid Biochem; 1977 Jul; 8(7):781-6. PubMed ID: 73629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of norethindrone and individual metabolites in human plasma during short- and long-term administration of a contraceptive dosage.
    Braselton WE; Lin TJ; Ellegood JO; Mills TM; Mahesh VB
    Am J Obstet Gynecol; 1979 Jan; 133(2):154-60. PubMed ID: 369375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of norethisterone oenanthate in humans.
    Sang GW; Fotherby K; Howard G; Elder M; Bye PG
    Contraception; 1981 Jul; 24(1):15-27. PubMed ID: 7273765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of norethindrone: peripheral plasma levels after oral administration to humans and rhesus monkeys.
    Nygren KG; Lindberg P; Martinsson K; Bosu WT; Johansson ED
    Contraception; 1974 Mar; 9(3):265-78. PubMed ID: 4442276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
    Eldon MA; Underwood BA; Randinitis EJ; Sedman AJ
    Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of norethisterone in women with subcutaneous implants of norethisterone acetate.
    Joshi JV; Naik VK; Joshi UM
    Indian J Med Res; 1979 Oct; 70():625-31. PubMed ID: 541006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between St John's wort and an oral contraceptive.
    Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
    Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
    Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contraceptive efficacy of norethindrone acetate (ENTA) implant: its release rate and fertility potential.
    Shahani SM; Kulkarni PP; Laumas KR
    J Obstet Gynaecol India; 1983 Feb; 33(1):16-20. PubMed ID: 12265592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.